219 related articles for article (PubMed ID: 19962166)
1. Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival.
Moore J; Hyman N; Callas P; Littenberg B
Surgery; 2010 Mar; 147(3):358-65. PubMed ID: 19962166
[TBL] [Abstract][Full Text] [Related]
2. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
3. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
[TBL] [Abstract][Full Text] [Related]
4. Hospital lymph node counts and survival after radical cystectomy.
Hollenbeck BK; Ye Z; Wong SL; Montie JE; Birkmeyer JD
Cancer; 2008 Feb; 112(4):806-12. PubMed ID: 18085612
[TBL] [Abstract][Full Text] [Related]
5. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
Le Voyer TE; Sigurdson ER; Hanlon AL; Mayer RJ; Macdonald JS; Catalano PJ; Haller DG
J Clin Oncol; 2003 Aug; 21(15):2912-9. PubMed ID: 12885809
[TBL] [Abstract][Full Text] [Related]
6. Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care?
Parsons HM; Tuttle TM; Kuntz KM; Begun JW; McGovern PM; Virnig BA
J Am Coll Surg; 2012 Sep; 215(3):400-11. PubMed ID: 22683070
[TBL] [Abstract][Full Text] [Related]
7. Lymph node ratio: role in the staging of node-positive colon cancer.
Wang J; Hassett JM; Dayton MT; Kulaylat MN
Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
[TBL] [Abstract][Full Text] [Related]
8. Adequacy and importance of lymph node evaluation for colon cancer in the elderly.
Bilimoria KY; Stewart AK; Palis BE; Bentrem DJ; Talamonti MS; Ko CY
J Am Coll Surg; 2008 Feb; 206(2):247-54. PubMed ID: 18222376
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD
Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262
[TBL] [Abstract][Full Text] [Related]
10. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
11. Surgical volume influences survival in patients undergoing resections for stage II colon cancers.
Morris M; Platell CF
ANZ J Surg; 2007 Oct; 77(10):902-6. PubMed ID: 17803560
[TBL] [Abstract][Full Text] [Related]
12. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
[TBL] [Abstract][Full Text] [Related]
14. Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?
Gleisner AL; Mogal H; Dodson R; Efron J; Gearhart S; Wick E; Lidor A; Herman JM; Pawlik TM
J Am Coll Surg; 2013 Dec; 217(6):1090-100. PubMed ID: 24045143
[TBL] [Abstract][Full Text] [Related]
15. Hospital lymph node examination rates and survival after resection for colon cancer.
Wong SL; Ji H; Hollenbeck BK; Morris AM; Baser O; Birkmeyer JD
JAMA; 2007 Nov; 298(18):2149-54. PubMed ID: 18000198
[TBL] [Abstract][Full Text] [Related]
16. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
17. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
[TBL] [Abstract][Full Text] [Related]
18. Acuity and survival in colon cancer surgery.
Paulson EC; Mahmoud NN; Wirtalla C; Armstrong K
Dis Colon Rectum; 2010 Apr; 53(4):385-92. PubMed ID: 20305436
[TBL] [Abstract][Full Text] [Related]
19. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.
Vather R; Sammour T; Kahokehr A; Connolly AB; Hill AG
Ann Surg Oncol; 2009 Mar; 16(3):585-93. PubMed ID: 19116751
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
